Charles River Laboratories International (MIL:1CRL) Cyclically Adjusted PB Ratio: (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
69 GF Score
Price €143.90
GF Value €121.74
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charles River Laboratories International  (MIL:1CRL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Charles River Laboratories International Cyclically Adjusted PB Ratio Related Terms


Charles River Laboratories International Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Cyclically Adjusted PB Ratio Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.59 6.95 6.36 4.25 4.05

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 3.24 3.24 4.05 3.37

MIL:1CRL vs RVTY, QGEN, ICLR: Cyclically Adjusted PB Ratio Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted PB Ratio falls into.


MIL:1CRL
69GF Score
Charles River Laboratories International Inc MIL:1CRL
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Charles River Laboratories International's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Charles River Laboratories International's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=51.684/330.2130*330.2130
=51.684

Current CPI (Mar. 2026) = 330.2130.

Charles River Laboratories International Quarterly Data

Book Value per Share CPI Adj_Book
201606 15.649 241.018 21.440
201609 16.342 241.428 22.352
201612 16.748 241.432 22.907
201703 17.203 243.801 23.300
201706 18.020 244.955 24.292
201709 18.110 246.819 24.229
201712 18.630 246.524 24.954
201803 19.297 249.554 25.534
201806 21.078 251.989 27.621
201809 22.329 252.439 29.208
201812 24.019 251.233 31.570
201903 25.383 254.202 32.973
201906 26.389 256.143 34.020
201909 28.489 256.759 36.639
201912 30.062 256.974 38.630
202003 30.211 258.115 38.650
202006 31.341 257.797 40.145
202009 32.381 260.280 41.081
202012 34.927 260.474 44.278
202103 36.532 264.877 45.543
202106 38.187 271.696 46.412
202109 40.876 274.310 49.206
202112 44.440 278.802 52.635
202203 46.654 287.504 53.584
202206 49.247 296.311 54.882
202209 52.148 296.808 58.017
202212 55.151 296.797 61.360
202303 56.728 301.836 62.061
202306 58.544 305.109 63.361
202309 60.389 307.789 64.789
202312 64.248 306.746 69.163
202403 65.019 312.332 68.741
202406 67.007 314.175 70.428
202409 66.645 315.301 69.797
202412 64.640 315.605 67.632
202503 60.159 319.799 62.118
202506 59.081 322.561 60.483
202509 58.954 324.800 59.937
202512 54.914 324.054 55.958
202603 51.684 330.213 51.684

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 18.2% above its estimated GF Value™ of €121.74.

Key valuation signals for MIL:1CRL:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €121.74 vs. price of €143.90 (18.2% above fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
69GF Score

Get the complete analysis for MIL:1CRL

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€121.74
GF Value